Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Terminated NCT06502990

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Conditions: Generalized Lipodystrophy

Sex: All

Ages: N/A – 5 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 1

Sponsor: Amryt Pharma

Location: UZ Leuven Leuven Leuven

Summary

This is an open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and/or hypertriglyceridaemia

Eligibility Criteria

Inclusion Criteria: * Confirmed diagnosis of Generalised Lipodystrophy * Metreleptin treatment naive Exclusion Criteria: * Weight \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06502990). StuddyBuddy aggregates publicly available trial information.